These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 10384858)

  • 1. Clinical pharmacology of new histamine H1 receptor antagonists.
    Simons FE; Simons KJ
    Clin Pharmacokinet; 1999 May; 36(5):329-52. PubMed ID: 10384858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy.
    Simons FE; Simons KJ
    Clin Pharmacokinet; 1991 Nov; 21(5):372-93. PubMed ID: 1685361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacology of H1 antihistamines: clinical relevance.
    Simons FE
    Am J Med; 2002 Dec; 113 Suppl 9A():38S-46S. PubMed ID: 12517581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of mizolastine.
    Lebrun-Vignes B; Diquet B; Chosidow O
    Clin Pharmacokinet; 2001; 40(7):501-7. PubMed ID: 11510627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative pharmacokinetics of H1-receptor antagonists.
    Simons FE; Simons KJ; Chung M; Yeh J
    Ann Allergy; 1987 Dec; 59(6 Pt 2):20-4. PubMed ID: 2892445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans.
    Molimard M; Diquet B; Benedetti MS
    Fundam Clin Pharmacol; 2004 Aug; 18(4):399-411. PubMed ID: 15312146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of ebastine in children.
    Simons FE; Watson WT; Simons KJ
    J Pediatr; 1993 Apr; 122(4):641-6. PubMed ID: 8096545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
    Grant JA; Riethuisen JM; Moulaert B; DeVos C
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects.
    Rohatagi S; Gillen M; Aubeneau M; Jan C; Pandit B; Jensen BK; Rhodes G
    Int J Clin Pharmacol Ther; 2001 Mar; 39(3):126-34. PubMed ID: 11396753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-generation antihistamines: a comparative review.
    Slater JW; Zechnich AD; Haxby DG
    Drugs; 1999 Jan; 57(1):31-47. PubMed ID: 9951950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New H1-receptor antagonists: clinical pharmacology.
    Simons FE
    Clin Exp Allergy; 1990 Aug; 20 Suppl 2():19-24. PubMed ID: 1977505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines).
    Paton DM; Webster DR
    Clin Pharmacokinet; 1985; 10(6):477-97. PubMed ID: 2866055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers: a phase I open-label study.
    Lasseter KC; Dilzer SC; Vargas R; Waldman S; Noveck RJ
    Clin Pharmacokinet; 2004; 43(2):121-9. PubMed ID: 14748620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsedating histamine H1-receptor antagonists.
    Mann KV; Crowe JP; Tietze KJ
    Clin Pharm; 1989 May; 8(5):331-44. PubMed ID: 2568212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cetirizine: a review of its use in allergic disorders.
    Curran MP; Scott LJ; Perry CM
    Drugs; 2004; 64(5):523-61. PubMed ID: 14977391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mizolastine: antihistaminic activity from preclinical data to clinical evaluation.
    Simons FE
    Clin Exp Allergy; 1999 Mar; 29 Suppl 1():3-8. PubMed ID: 10209699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations among non-sedating antihistamines: are there real differences?
    Mattila MJ; Paakkari I
    Eur J Clin Pharmacol; 1999 Apr; 55(2):85-93. PubMed ID: 10335901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of the histamine H1-receptor antagonist ebastine and its active metabolite carebastine in rats, guinea pigs, dogs and monkeys.
    Matsuda M; Sakashita M; Mizuki Y; Yamaguchi T; Fujii T; Sekine Y
    Arzneimittelforschung; 1994 Jan; 44(1):55-9. PubMed ID: 7907872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and electrocardiographic effect of ebastine in young versus elderly healthy subjects.
    Huang MY; Argenti D; Wilson J; Garcia J; Heald D
    Am J Ther; 1998 May; 5(3):153-8. PubMed ID: 10099053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.